Male birth control pill shows promising results in first human trial
Previously, the pill showed 99% efficacy previously in mice and male monkey experiments, in which fertility was regained within 6 weeks in mice and 10 to 15 weeks in monkeys.Unlike other experimental male contraceptives, YCT-529 does not affect hormone levels, making it potentially safer and more appealing for long-term use.In this first-ever human study, 16 healthy male volunteers were given single doses of the pill in varying strengths - 10, 30, 90, and 180 mg.They were monitored closely for side effects and changes in vital health indicators, including heart rate, mood, sexual desire, and hormone levels.The results were encouraging: no major side effects were reported and the drug did not affect testosterone or other reproductive hormone levels.Mood and libido remained unchanged, easing concerns about psychological or sexual side effects.Even the highest dose of 180 mg was well tolerated.Researchers also tested how the drug behaved when taken with food and found no major difference, meaning it could be taken with or without meals.This was a Phase 1a trial, which is designed to test the safety of a drug before moving on to larger studies that look at how effective it is at its intended purpose, in this case, reducing sperm count to prevent pregnancy.While it's still early days, the success of YCT-529 in this trial is a hopeful sign for the future of non-hormonal male birth control—a field that hasn't seen much progress in the last 50 years.- Ends
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
2 hours ago
- NDTV
'Cannibal' Robot That Can Grow, Heal By Consuming Other Bots Developed
In what appears to be a scene straight out of a dystopian sci-fi movie, scientists at Columbia University in New York have developed a robot capable of growing and healing by consuming other robots. Researchers say the development marks a big step in the creation of self-sustaining machines that can lead to an entirely new dimension of autonomy for artificial intelligence. "It is possible to form machines that can grow physically and become more capable within their lifetime by consuming and recycling material from their immediate surroundings and other machines," the study published in the journal Science Advances highlighted. The so-called cannibal robot works through a process called "robot metabolism", allowing it to self-assemble and increase its performance by adding new bits, or discarded old parts that have run out of battery or no longer serve a function. The researchers showed how Truss Links -- a robotic magnet stick inspired by the Geomag toy, self-assembled into two-dimensional shapes, which could later morph into three-dimensional robots. These robots then further improved themselves by integrating new parts, effectively "growing" into more capable machines. "Truss Links can be used to build modular robots. Modular robot systems comprise multiple parts called modules, links, or cells that can self-assemble or be assembled to achieve an objective. The Truss Link is the basic building block of our modular robot system," Also Read | Japan's Toll System Crashes For 38 Hours, 24,000 Still Voluntarily Pay The Fees Though the development of self-sustaining robots is still in a nascent stage, the researchers say the creation of Truss Links is a step toward a future where robots can adapt and improvise "instead of being purpose-built with the vain hope of anticipating all use cases". "True autonomy means robots must not only think for themselves but also physically sustain themselves," Philippe Martin Wyder, lead author and researcher, said in a statement. "Just as biological life absorbs and integrates resources, these robots grow, adapt, and repair using materials from their environment or from other robots." 'What can go wrong' Reacting to the news of self-sustaining robots that might become the norm in the future, social media users were divided on their use case. "Why we need this? What is the purpose of that in our world?" wrote one user while another added: "Oh lovely, real life replicators! What can go wrong?"
Time of India
a day ago
- Time of India
The unexpected risk Ivy League students face using ChatGPT in class
How Ivy League universities in the US are managing ChatGPT and AI misuse. (AI Image) The rapid adoption of artificial intelligence tools such as ChatGPT has introduced new challenges in US higher education, especially within Ivy League universities. These prestigious institutions are grappling with how to integrate AI in learning while maintaining academic integrity. As reported by Forbes, the use of generative AI presents both opportunities and risks for students, educators and the institutions themselves. Ivy League schools have not imposed blanket rules on AI use, but instead emphasise the autonomy of individual instructors to determine policies in their courses. This approach reflects the complexity of AI's impact on learning outcomes and academic honesty, and it places responsibility on students to understand when and how AI can be used appropriately. Instructor and course autonomy define AI policies Princeton University's official policy states that if generative AI is permitted by the instructor, students must disclose its use but not cite it as a source since AI is considered an algorithm rather than an author. The policy further advises students to familiarise themselves with departmental regulations regarding AI use, as reported by Forbes. Similarly, Dartmouth College allows instructors to decide whether AI tools can be used based on intended learning outcomes. This decentralised system means that students cannot assume uniformity in AI policies across courses, even within the same institution. A student permitted to use AI for brainstorming in one class might find it prohibited in another. This variation extends to disciplines; STEM courses may allow wider use of AI tools, while humanities departments like English often restrict AI to preserve critical thinking and originality. AI misuse is considered academic dishonesty Several Ivy League schools, including the University of Pennsylvania and Columbia University, have clearly stated that misuse of generative AI constitutes academic dishonesty. According to Forbes, students who improperly use AI may face disciplinary measures similar to those for plagiarism. Understanding how AI functions is critical for students to make informed decisions about its use. They need to be able to evaluate AI-generated content critically, identify hallucinations or inaccuracies, and disclose AI assistance when allowed. As Forbes reports, schools also emphasise the importance of respecting intellectual property rights, warning against uploading confidential or proprietary information to AI platforms without proper protections in place. Policies are evolving alongside AI technology Given the fast pace of AI development, Ivy League institutions regularly review and update their AI guidelines. Columbia University notes that guidance on generative AI use is expected to evolve as experience with the technology grows, as reported by Forbes. Faculty are encouraged to experiment with new pedagogical methods and adapt their course policies to reflect changing realities. Students preparing for collegiate study are advised to develop technological literacy and critical thinking skills to navigate these shifting policies successfully. The indiscriminate use of AI tools may hinder their ability to demonstrate independent thought, a quality highly valued by Ivy League admissions and faculty alike. In summary, Ivy League students face the unexpected risk of navigating a complex and evolving landscape of AI policies. While generative AI offers powerful tools for learning, misuse or overreliance can lead to academic consequences. Awareness, transparency and critical engagement with AI are essential to avoid these risks, as these elite US institutions continue to balance innovation with academic standards. TOI Education is on WhatsApp now. Follow us here . Ready to navigate global policies? Secure your overseas future. Get expert guidance now!
Mint
3 days ago
- Mint
Male contraceptive YCT-529 a breakthrough? Birth control pill that temporarily halts sperm without hormones clears trial
In a new development, men may soon be able to equitably share the responsibility of avoiding pregnancy along with their partners as YCT-529, a birth control experimental pill has passed its initial human safety test, making another way for contraception. It will reportedly cease sperms temporarily without hinderance to hormones. Unlike conventional hormonal birth control pills, the innovative pill developed by YourChoice Therapeutics temporarily halts sperm production while leaving testosterone levels unchanged, New York Post reported. It functions by inhibiting a protein named retinoic acid receptor alpha, which is essential in the sperm creation process. Initial studies indicate that its effects are completely reversible. In tests involving male mice, YCT-529 significantly decreased sperm production, leading to reversible infertility after only four weeks of treatment. When these treated males bred with females, the drug demonstrated a 99% success rate in preventing pregnancy. Comparable outcomes were observed in male nonhuman primates, with sperm counts declining within two weeks of beginning the treatment. Importantly, fertility was fully restored in both species once the drug was discontinued. Mice recovered within six weeks, while primates regained fertility between 10 and 15 weeks. No side effects were noted in either group throughout the studies, the report added. The initial human trial of the medication included 16 healthy males aged 32 to 59, all of whom had previously had vasectomies, a surgical operation that severs and blocks the tubes transporting sperm from the testicles to prevent conception. This additional safety measure was required because no nonhormonal male contraceptive had ever been evaluated in humans before. Scientists wanted to eliminate any chance of permanently impacting fertility, in case participants wished to have children later, Nadja Mannowetz, co-founder and chief science officer of YourChoice Therapeutics, informed Scientific American. She clarified the objective was not to assess effectiveness but to determine if the drug was tolerated well and to observe how it accumulated in the body. Researchers tested multiple doses and found no concerning side effects. There were no changes in heart rate, hormone levels, inflammation, sexual function, or mood. This finding is important because hormonal contraceptives have previously been linked to side effects like mood swings, decreased libido, weight gain, and acne. Mannowetz pointed out that across all doses, the drug demonstrated good and rapid bioavailability, which means it remained active in the body without breaking down too quickly, the report mentioned.
